WuXi Biortus Raises $15 Million for Cryo-EM Drug Discovery CRO

Wuxi Biortus Biosciences, a drug discovery CRO, closed a $15 million Series A financing led by Bayland Capital. Biortus will use the funds to build a cryogenic electron microscopy (cryo-EM) innovation center to offer structure-based drug discovery services. In 2018, the company launched the first commercial gene-to-structure one-stop-shop cryo-EM platform. It believes cryo-EM  has the ability to transform traditional structural biology methodologies by delivering atomic resolution information on membrane proteins and large protein complexes. More details.... Share this with colleagues: // //